TAKEDA PHARMA OÜ
Date of report 26.11.2024
TAKEDA PHARMA OÜ
Former names
- aktsiaselts Nycomed Sefa
- aktsiaselts Takeda Pharma
- Takeda Pharma AS
start | end |
---|---|
01.01.1994 | - |
keywords
- muud äritegevuse abiteenused
TAKEDA PHARMA OÜ
Scores and ratings
Reputation score
Credit Score
Open the reports you want to print
Employees and salaries
TAKEDA PHARMA OÜ
Employee taxes and performance analysisQuarter | Labor taxes paid | Number of employees | Turnover Per Employee | Profit per employee |
---|---|---|---|---|
2024 III | ...... | ...... | ...... | ...... |
2024 II | ...... | ...... | ...... | ...... |
2024 I | ...... | ...... | ...... | ...... |
2023 IV | ...... | ...... | ...... | ...... |
2023 III | ...... | ...... | ...... | ...... |
2023 II | ...... | ...... | ...... | ...... |
2023 I | ...... | ...... | ...... | ...... |
2022 IV | ...... | ...... | ...... | ...... |
2022 III | ...... | ...... | ...... | ...... |
2022 II | ...... | ...... | ...... | ...... |
2022 I | ...... | ...... | ...... | ...... |
2021 IV | ...... | ...... | ...... | ...... |
2021 III | ...... | ...... | ...... | ...... |
2021 II | ...... | ...... | ...... | ...... |
2021 I | ...... | ...... | ...... | ...... |
2020 IV | ...... | ...... | ...... | ...... |
2020 III | ...... | ...... | ...... | ...... |
2020 II | ...... | ...... | ...... | ...... |
2020 I | ...... | ...... | ...... | ...... |
2019 IV | ...... | ...... | ...... | ...... |
2019 III | ...... | ...... | ...... | ...... |
2019 II | ...... | ...... | ...... | ...... |
2019 I | ...... | ...... | ...... | ...... |
2018 IV | ...... | ...... | ...... | ...... |
2018 III | ...... | ...... | ...... | ...... |
2018 II | ...... | ...... | ...... | ...... |
2018 I | ...... | ...... | ...... | ...... |
2017 IV | ...... | ...... | ...... | ...... |
2017 III | ...... | ...... | ...... | ...... |
2017 II | ...... | ...... | ...... | ...... |
2017 I | ...... | ...... | ...... | ...... |
2016 IV | ...... | ...... | ...... | ...... |
2016 III | ...... | ...... | ...... | ...... |
2016 II | ...... | ...... | ...... | ...... |
2016 I | ...... | ...... | ...... | ...... |
2015 IV | ...... | ...... | ...... | ...... |
2015 III | ...... | ...... | ...... | ...... |
2015 II | ...... | ...... | ...... | ...... |
2015 I | ...... | ...... | ...... | ...... |
Deciders and beneficiaries
TAKEDA PHARMA OÜ
DecidersFormer deciders
......
Credit Score: Trustworthy
Reputation scores: 5050
Date of birth: ......
Active relations 1
0 followers
......
Credit Score: Trustworthy
Reputation scores: 5050
Date of birth: ......
Active relations 1
0 followers
......
Credit Score: Trustworthy
Reputation scores: 5050
Date of birth: ......
Active relations 1
0 followers
......
Credit Score: Trustworthy
Reputation scores: 5050
Date of birth: ......
Active relations 1
0 followers
......
Credit Score: Trustworthy
Reputation scores: 5050
Date of birth: ......
Active relations 1
12 followers
TAKEDA PHARMA OÜ
Former deciders......
Credit Score: Neutral
Reputation scores: 780
Date of birth: ......
Active relations 2
19 followers
......
Credit Score: None
Reputation scores: None
Date of birth: ......
Active relations 0
0 followers
......
Credit Score: None
Reputation scores: None
Date of birth: ......
Active relations 0
0 followers
......
Credit Score: Trustworthy
Reputation scores: 4390
Date of birth: ......
Active relations 3
1 follower
......
Credit Score: Trustworthy
Reputation scores: 4390
Date of birth: ......
Active relations 3
1 follower
TAKEDA PHARMA OÜ
History of right of representationTAKEDA PHARMA OÜ
OwnersFormer owners
Name | Credit Score | Payment | Beginning | Type | Holding |
---|---|---|---|---|---|
...... | ...... | ...... |
100%
|
TAKEDA PHARMA OÜ
Other related partiesFormer other persons
Other related parties (invalid relations)
Name | Credit Score | Part | Beginning | End |
---|---|---|---|---|
...... | ...... | ...... | ||
...... | ...... | ...... | ||
...... | ...... | ...... | ||
...... | ...... | ...... | ||
...... | ...... | ...... | ||
...... | ...... | ...... | ||
...... | ...... | ...... | ||
...... | ...... | ...... | ||
...... | ...... | ...... | ||
...... | ...... | ...... | ||
...... | ...... | ...... | ||
...... | ...... | ...... | ||
...... | ...... | ...... | ||
...... | ...... | ...... | ||
...... | ...... | ...... | ||
...... | ...... | ...... | ||
...... | ...... | ...... | ||
...... | ...... | ...... | ||
...... | ...... | ...... | ||
...... | ...... | ...... | ||
...... | ...... | ...... | ||
...... | ...... | ...... | ||
...... | ...... | ...... | ||
...... | ...... | ...... | ||
...... | ...... | ...... | ||
...... | ...... | ...... | ||
...... | ...... | ...... | ||
...... | ...... | ...... | ||
...... | ...... | ...... | ||
...... | ...... | ...... | ||
...... | ...... | ...... | ||
...... | ...... | ...... | ||
...... | ...... | ...... | ||
...... | ...... | ...... | ||
...... | ...... | ...... | ||
...... | ...... | ...... | ||
...... | ...... | ...... | ||
...... | ...... | ...... |
TAKEDA PHARMA OÜ
Subsidiaries and associatesFormer subsidiaries and associates
Finances and assets
TAKEDA PHARMA OÜ
GoodwillTAKEDA PHARMA OÜ
Paid taxes and estimated average salariesTAKEDA PHARMA OÜ
Quarterly indicatorsQuarter | Turnover | Taxed turnover | Labor productivity | Labor productivity | Employees | National taxes | Labor taxes |
---|---|---|---|---|---|---|---|
2024 III | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
2024 II | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
2024 I | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
2023 IV | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
2023 III | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
2023 II | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
2023 I | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
2022 IV | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
2022 III | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
2022 II | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
2022 I | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
2021 IV | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
2021 III | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
2021 II | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
2021 I | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
2020 IV | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
2020 III | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
2020 II | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
2020 I | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
2019 IV | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
2019 III | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
2019 II | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
2019 I | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
2018 IV | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
2018 III | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
2018 II | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
2018 I | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
2017 IV | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
2017 III | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
2017 II | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
2017 I | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
2016 IV | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
2016 III | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
2016 II | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
2016 I | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
2015 IV | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
2015 III | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
2015 II | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
2015 I | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
TAKEDA PHARMA OÜ
Sales revenue by business areaTAKEDA PHARMA OÜ
Sales revenue by countryTAKEDA PHARMA OÜ
Financial indicators and prognosisTAKEDA PHARMA OÜ
Financial raiting: "VERY GOOD" (2024 prognosis)TAKEDA PHARMA OÜ
Annual reportsYear | Period | Submitted | Report PDF |
---|---|---|---|
2023 | 01.04.2023–31.03.2024 | 01.08.2024 | ...... |
2022 | 01.04.2022–31.03.2023 | 22.09.2023 | ...... |
2021 | 01.04.2021–31.03.2022 | 07.10.2022 | ...... |
2020 | 01.04.2020–31.03.2021 | 19.10.2021 | ...... |
2019 | 01.04.2019–31.03.2020 | 28.09.2020 | ...... |
2018 | 01.04.2018–31.03.2019 | 09.03.2020 | ...... |
2017 | 01.04.2017–31.03.2018 | 05.09.2018 | ...... |
2016 | 01.04.2016–31.03.2017 | 29.09.2017 | ...... |
2015 | 01.04.2015–31.03.2016 | 22.09.2016 | ...... |
2014 | 01.04.2014–31.03.2015 | 10.07.2015 | ...... |
2013 | 01.04.2013–31.03.2014 | 04.07.2014 | ...... |
2012 | 01.04.2012–31.03.2013 | 12.07.2013 | ...... |
2011 | 01.04.2011–31.03.2012 | 08.06.2012 | ...... |
2010 | 01.04.2010–31.03.2011 | 16.06.2011 | ...... |
2009 | 01.04.2009–31.03.2010 | 28.06.2010 | ...... |
2008 | 01.04.2008–31.03.2009 | 17.06.2009 | ...... |
2007 | 01.04.2007–31.03.2008 | 18.06.2008 | ...... |
2006 | 01.04.2006–31.03.2007 | 25.06.2007 | ...... |
2005 | 01.04.2005–31.03.2006 | 29.06.2006 | ...... |
2004 | 01.04.2004–31.03.2005 | 29.06.2005 | ...... |
2003 | 01.04.2003–31.03.2004 | 01.07.2004 | ...... |
2002 | 01.04.2002–31.03.2003 | 01.07.2003 | ...... |
2001 | 01.04.2001–31.03.2002 | 03.07.2002 | ...... |
2000 | 01.04.2000–31.03.2001 | 04.07.2001 | ...... |
Liabilities and debts
TAKEDA PHARMA OÜ
Credit score history and prognosis... €
......
Business risk classes:
Trustworthy NeutralTAKEDA PHARMA OÜ
Reports and assets-liabilities overview 26.11.2024TAKEDA PHARMA OÜ
Claims historyTotal debt claims: ...... €
...... | ...... |
TAKEDA PHARMA OÜ
Income (turnover) and expenditure (taxes paid)Quarter | Turnover | Taxed turnover | National taxes paid | Labor taxes paid | Number of employees |
---|---|---|---|---|---|
2024 III | * ...... € | ...... € | ...... € | ...... € | ...... |
2024 II | * ...... € | ...... € | ...... € | ...... € | ...... |
2024 I | * ...... € | ...... € | ...... € | ...... € | ...... |
2023 IV | * ...... € | ...... € | ...... € | ...... € | ...... |
2023 III | * ...... € | ...... € | ...... € | ...... € | ...... |
2023 II | * ...... € | ...... € | ...... € | ...... € | ...... |
2023 I | * ...... € | ...... € | ...... € | ...... € | ...... |
2022 IV | * ...... € | ...... € | ...... € | ...... € | ...... |
2022 III | * ...... € | ...... € | ...... € | ...... € | ...... |
2022 II | * ...... € | ...... € | ...... € | ...... € | ...... |
2022 I | * ...... € | ...... € | ...... € | ...... € | ...... |
2021 IV | * ...... € | ...... € | ...... € | ...... € | ...... |
2021 III | * ...... € | ...... € | ...... € | ...... € | ...... |
2021 II | * ...... € | ...... € | ...... € | ...... € | ...... |
2021 I | * ...... € | ...... € | ...... € | ...... € | ...... |
2020 IV | * ...... € | ...... € | ...... € | ...... € | ...... |
2020 III | * ...... € | ...... € | ...... € | ...... € | ...... |
2020 II | * ...... € | ...... € | ...... € | ...... € | ...... |
2020 I | * ...... € | ...... € | ...... € | ...... € | ...... |
2019 IV | * ...... € | ...... € | ...... € | ...... € | ...... |
2019 III | * ...... € | ...... € | ...... € | ...... € | ...... |
2019 II | * ...... € | ...... € | ...... € | ...... € | ...... |
2019 I | * ...... € | ...... € | ...... € | ...... € | ...... |
2018 IV | * ...... € | ...... € | ...... € | ...... € | ...... |
2018 III | * ...... € | ...... € | ...... € | ...... € | ...... |
2018 II | * ...... € | ...... € | ...... € | ...... € | ...... |
2018 I | * ...... € | ...... € | ...... € | ...... € | ...... |
2017 IV | * ...... € | ...... € | ...... € | ...... € | ...... |
2017 III | * ...... € | ...... € | ...... € | ...... € | ...... |
2017 II | * ...... € | ...... € | ...... € | ...... € | ...... |
2017 I | * ...... € | ...... € | ...... € | ...... € | ...... |
2016 IV | * ...... € | ...... € | ...... € | ...... € | ...... |
2016 III | * ...... € | ...... € | ...... € | ...... € | ...... |
2016 II | * ...... € | ...... € | ...... € | ...... € | ...... |
2016 I | * ...... € | ...... € | ...... € | ...... € | ...... |
2015 IV | * ...... € | ...... € | ...... € | ...... € | ...... |
2015 III | * ...... € | ...... € | ...... € | ...... € | ...... |
2015 II | * ...... € | ...... € | ...... € | ...... € | ...... |
2015 I | * ...... € | ...... € | ...... € | ...... € | ...... |
TAKEDA PHARMA OÜ
Bailiff's enforcement proceedings as of 26.11.2024Bailiff's enforcement proceedings MISSING
TAKEDA PHARMA OÜ
Regulations of the Payment Order Department as of 26.11.2024Regulations of the Payment Order Department MISSING
TAKEDA PHARMA OÜ
Court orders in the register as of 26.11.2024Puuduste kõrvaldamise määrus kandeväliste andmete parandamiseks
Regulation number: Ä 20010336 / M18
Regulation status has entered into force: 30.05.2022
Date of enforcement of order or additional period: 24.05.2022
Määruse olek: Puudused kõrvaldatud
TAKEDA PHARMA OÜ
Decisions of the Consumer Disputes Committee as of 26.11.2024Consumer disputes MISSING
TAKEDA PHARMA OÜ
Court hearings as of 26.11.2024Court hearings MISSING
TAKEDA PHARMA OÜ
Rulings as of 26.11.2024Court settlemets MISSING
TAKEDA PHARMA OÜ
Notices and announcements as of 26.11.2024Company Transformation Notice
Avaldamise lõpp: tähtajatu
Ühing teatab ümberkujundamisest.
Võlausaldajatel palume esitada oma nõuded tagatise saamiseks kuue kuu jooksul käesoleva teate avaldamisest. (ÄS § 483 lg 1). ee.info@takeda.com
Kristiine linnaosa, Tallinn, Harju maakond, Järve tn 2
Telefon: +372 6177669
E-post: ee.info@takeda.com
PIRET TUUL
Notice of merger
Avaldamise lõpp: tähtajatu
Ühing teatab ühinemisest. Ühinemisel osalesid Takeda Pharma AS (registrikood 10323690) ja Baxalta Estonia OÜ (registrikood: 12960998), asukoht: Pirita tee 20/2 Tallinn 10127.
Äriühingute võlausaldajatel palume esitada oma nõuded tagatise saamiseks kuue kuu jooksul käesoleva teate avaldamisest (ÄS § 399 lg 1).
Põlva linn, Põlva vald, Põlva maakond, Jaama tn 55b
Telefon: +372 6177669
E-post: info@takeda.ee
Piret Tuul
Notice of concluding a merger agreement of a public limited company
Avaldamise lõpp: tähtajatu
Aktsiaselts teatab ühinemislepingu sõlmimisest. Ühinemisleping on sõlmitud Takeda Pharma AS (registrikood 10323690) ja Baxalta Estonia OÜ (registrikood: 12960998), asukoht: Pirita tee 20/2 Tallinn 12011 vahel.
Ühinemislepingu ja teiste dokumentidega on võimalik tutvuda ja saada nende ärakirju allolevatel kontaktidel.
Põlva linn, Põlva vald, Põlva maakond, Jaama tn 55b
Telefon: +372 6177669
E-post: info@takeda.ee
Piret Tuul
Marketing
Business network
TAKEDA PHARMA OÜ
Business networkSign in
To expand your connections, log in to the "Networks" environment
Beneficiaries network
TAKEDA PHARMA OÜ
Networks - BeneficiariesSign in
To expand your connections, log in to the "Networks" environment
Monitoring events
Filter
Dropdown
Dropdown
Neutral
Positive
Negative
No monitoring events were found
Failed to load monitoring events